BIOCON Share Price Discussion

Biocon Ltd.
Sector: Pharmaceuticals and health care

BIOCON Share Price *

288.95 +2.35 (0.82%)

* (quote may be delayed)

Find answers to all your questions on live BIOCON message board: Is BIOCON buy or sell? Should I buy BIOCON shares? Why are BIOCON shares falling? Should I invest in BIOCON stock?

You can also check BIOCON share price target recommended by brokerages.

BIOCON Discussion Forum

Sridhar Balakri... @sridharbala...

BIOCON

•

Yesterday 11:42 PM

Performance for the WEEK*
Futures & Options educational trades for the week 2.12.19 to 6.12.19*
BIOCON CE 280* cmp 13.00 buy upto 7.00 stop 4.00 target 27.00+
Entry 13.50 to 23.00 
*profit ₹ 17100*

Krishna Attri @attri

BIOCON

•

Dec 5 7:46 PM

#Biocon trying to come below its Support. #BSE #SENSEX #NIFTY

Sameer @tradingfab

BIOCON

•

Dec 5 3:51 PM

05-12-19
BIOCON SELL FUT DEC (Intraday)
only below @ 285.40

Reply (3)

Latest replies

Sameer @tradingfab

•

Dec 5 4:15 PM

LOW 285 *****************

Sameer @tradingfab

•

Dec 5 4:23 PM

LOW 284.80 **************

Sameer @tradingfab

•

Dec 5 5:05 PM

LOW 284.50 **********************

Sridhar Balakri... @sridharbala...

BIOCON

•

Dec 3 10:26 PM

BIOCON
Entry 13.50 to 23.00 (cmp 15.40) 
*profit ₹ 17100*

sahil gera @sahilgera

BIOCON

•

Dec 3 2:50 PM

Q. Any view on biocon

Reply (9)

Latest replies

Invictus @invictotrader

•

Dec 3 3:43 PM

If it sustained 288-291 then buy risky call

Invictus @invictotrader

•

Dec 3 4:03 PM

One thing keep in mind, buy the rumours sell the news, when there is any news on particular company just avoid.

Invictus @invictotrader

•

Dec 3 4:57 PM

Making support, healthy living sign

HIDDEN GEM @hidden

•

Dec 4 1:17 AM

SHORT BIOCON 290-300 WITH SL 308 POSITIONAL TGTS 272-248**

Profitmaker @Profitmaker

•

Dec 4 1:42 AM

320 act as a major resisitance  for this month we can sell from this level

KONAR TRADE TALK ™ @konartradetalk

BIOCON

•

Dec 3 2:02 PM

💠💠
YOUR FREE EQUITY CASH CALL FOR THIS FORUM TODAY:
BUY BIOCON AT THE VERY BEGINING
STRICT STOP LOSS - 280.95
TARGET - 289/291/293
## AVOID IF IT OPEN 3% AND HIGHER##
Disclaimer: All my Views/Suggestions/Calls are for Education Purpose Only. Please consult with your financial a...

TradeAdda @nishantshah91

BIOCON

•

Nov 26 6:25 PM

BIOCON
Super Move Made High 270 from 256.30 Made us wait but delivered the Goods. Target 1 270  done Now . Book Half and Trail Rest to cost. 
#TradeAdda #biocon

TradeAdda @nishantshah91

BIOCON

•

Nov 26 5:04 PM

TradeAdda in BIOCON
Biocon #Nse #Bse #equity #Positional #TradeAdd...

Only 2% voted for Biocon but Now Biocon also moving nicely towards Target 1 270. New High 266.95 🚀 10 points/5 % plus move done in a day.

TradeAdda @nishantshah91

BIOCON

•

Nov 26 4:58 PM

TradeAdda in BIOCON
Biocon #Nse #Bse #equity #Positional #TradeAdd...

BIOCON
Super Move Made High 265.50 remember bought yesterday at 256.30 Move Started Now. Ready for Target 1 270.
#TradeAdda

TradeAdda @nishantshah91

BIOCON

•

Nov 25 4:35 PM

TradeAdda in BIOCON
Biocon #Nse #Bse #equity #Positional #TradeAdd...

Biocon
Made high intraday 259.75 from open 256.30
#TradeAdda #biocon

TradeAdda @nishantshah91

BIOCON

•

Nov 25 2:31 PM

Biocon
#Nse #Bse #equity #Positional #TradeAdda #stockmarket #breakout #bullish
For Educational Purposes only.
#TradeAdda

Reply (1)

Latest replies

TradeAdda @nishantshah91

•

Nov 26 5:38 PM

BIOCON
Super Move Made High 268.50 from 256.30 Made us wait but delivered the Goods. Target 1 270 almost done Now . Book Half and Trail Rest to cost. Enjoy. 
#TradeAdda #biocon

Calls Unlimited @calls

BIOCON

•

Nov 21 5:09 PM

BIOCON GIVEN AT 263 YDAY
NOW MADE 257 + 6000
DERISK N HOLD
CHAPO INDIA CHAPO

Calls Unlimited @calls

BIOCON

•

Nov 15 4:09 PM

ENTERING AGAIN 257

Calls Unlimited @calls

BIOCON

•

Nov 14 5:05 PM

Calls Unlimited in BIOCON
BIOCON PATIENCE - PAYS 266 TO 259 + 7000 DERI...

BIOCON GIVEN AT 264
NOW MADE 250 + 14000
CHAPO INDIA CHAPO

Calls Unlimited @calls

BIOCON

•

Nov 13 5:45 PM

Calls Unlimited in BIOCON
BIOCON PATIENCE - PAYS 266 TO 259 + 7000 DERI...

BIOCON
FREE FALL
266 TO 258 + 8000

Daily Winner @level

BIOCON

•

Nov 13 5:18 PM

Daily Winner in BIOCON
buy biocon sl 259.90 tgt 267.90 cmp 262.80

So gone ab reverse 257

Calls Unlimited @calls

BIOCON

•

Nov 13 4:52 PM

Calls Unlimited in BIOCON
266 WE WILL ENTER SHORT SOON

BIOCON  
PATIENCE - PAYS
266 TO 259 + 7000
DERISK N HOLD 
CHAPO INDIA CHAPO

Daily Winner @level

BIOCON

•

Nov 13 3:31 PM

buy biocon sl 259.90 tgt 267.90 cmp 262.80

Daily Winner @level

BIOCON

•

Nov 13 3:31 PM

buy biocon sl 259.90 tgt 267.90 cmp 262.80

Hustle With Ich... @hustlewithme

BIOCON

•

Nov 10 3:06 AM

Biocon 265 target 280 
( holding myself from 230 levels) 
Investors can Ping me to know details on whatsapp

Jyoti Soni @jyotisoni

BIOCON

•

Nov 8 4:18 PM

Booked eqity 268

BIOCON - Share Price - Fundamentals
Market Capitalization 36,660
Enterprise Value 36,305
Price to Earnings 149.8
Price to Book Value 5.15
Return on Capital Employed 0.04
Return on Equity 0.04
Face Value 5
Dividend Yield NA
BIOCON Share Price - Technicals
BIOCON - 52 Week High ₹682.45
BIOCON - 52 Week Low ₹211.05
BIOCON - Brokerage Reports
Date Brokerage Call Target
30-Oct-19 Geojit Financial Services Hold 260
24-Oct-19 ICICIdirect.com Buy 310
24-Oct-19 Nirmal Bang Accumulate 252
2-Aug-19 AnandRathi Buy 321
2-Aug-19 Axis Direct Buy 300
BIOCON Brokerage Price Target
BIOCON Share Price - Historical (₹)
Date Open High Low Close
Dec 6 288.05 293.35 286.05 289
Dec 5 287.2 289.25 283.9 286.6
Dec 4 284 289 281.15 287.2
Dec 3 299 299 282.85 285.7
Dec 2 283.2 291.95 282.45 285.8
BIOCON Share Price - Daily Moving Averages (DMA)
20 Day Moving Average ₹269.42
30 Day Moving Average ₹263.29
50 Day Moving Average ₹252.7
100 Day Moving Average ₹243.42
200 Day Moving Average ₹386.93
BIOCON - Profit And Loss
CONSOLIDATED Mar-18 Mar-17 % Change
Revenue 2,425 2,587.9 -0.06
Operating Profit 318 591.8 -0.46
Profit Before Tax 305 536.2 -0.43
Net Income 238 519.3 -0.54
BIOCON - Balance Sheet
CONSOLIDATED Mar-19 Mar-18 % Change
Shareholder's Funds 7,115 6,737 0.06
Total Liabilities 1,125 1,045 0.08
Total Assets 8,240 7,783 0.06
BIOCON - Cash Flow
CONSOLIDATED Mar-18 Mar-17 % Change
Cash from Operating Activity 355 185.8 0.91
Cash from Investing Activity -553 104 -6.32
Cash from Financing Activity -54 -238.3 -0.77
Net Cash Flow -252 51.5 -5.89
BIOCON - Ratios
CONSOLIDATED Mar-18 Mar-17
Return on Assets 0.03 0.07
Return on Equity 0.04 0.08
Return on Capital Employed 0.04 0.08
BIOCON - 3 year Growth
3 Year CAGR Growth in Revenue 0.08
3 Year CAGR Growth in Operating Profit -0.22
3 Year CAGR Growth in EBIDTA -0.21
3 Year CAGR Growth in Net Income -0.34
3 Yr CAGR Growth - Diluted EPS -0.78
BIOCON - 5 year Growth
5 Year CAGR Growth in Revenue 0.25
5 Year CAGR Growth in Operating Profit -0.18
5 Year CAGR Growth in EBIDTA NA
5 Year CAGR Growth in Net Income -0.14
3 Yr CAGR Growth - Diluted EPS -0.71
BIOCON - Recent News
NewsBot
Oct 24 9:03 PM
Biocon, Indian Bank decline 6-12% after Q2 earnings
Moneycontrol
NewsBot
Oct 24 1:53 PM
Market Headstart: Nifty50 seen opening higher; HCL Tech, Hero MotoCorp eyed
Moneycontrol
NewsBot
Oct 24 2:18 AM
Biocon Q2 net profit at Rs 216 cr
Moneycontrol
NewsBot
Oct 12 5:08 PM
Stock movers for the week: Bharti Airtel, Century Textiles, Bandhan Bank top the charts
Moneycontrol
NewsBot
Oct 11 5:23 PM
'Investors can deploy sell-on-rise stance for the coming week towards 11,400'
Moneycontrol
NewsBot
Oct 11 1:48 PM
Stocks in the news: Infosys, IndusInd Bank, TCS, Biocon, NCC, IOB, Tata Steel, BOI
Moneycontrol
NewsBot
Oct 9 4:13 PM
Strong support for Nifty at 11,000; HCL Tech, HDFC on analysts’ radar
Moneycontrol
NewsBot
Oct 7 2:13 PM
Podcast | Stock picks of the day: Nifty could find support around 11,050-10,800 levels
Moneycontrol
NewsBot
Oct 7 1:18 PM
A morning walk down Dalal Street | Avoid long positions, consider positional shorts on pull back towards 11,300
Moneycontrol
NewsBot
Oct 5 5:33 PM
DHFL, BPCL, Lakshmi Vilas Bank among 10 stocks that rose or fell the most in last week
Moneycontrol
BIOCON - Related Communities
MCX:RBDPMOLEIN
MCX:RBDPMOLEIN
MCX:PEPPER
MCX:PEPPER
MCX:CASTORSEED
MCX:CASTORSEED
MCX:CARDAMOM
MCX:CARDAMOM
MCX:BRASSPHY
MCX:BRASSPHY
AFFLE
Affle (India) Limited
MCX:COTTON
MCX:COTTON
SPICEJET
SPICEJET LTD Sector: Transport
IRCTC
IRCTC Sector: Miscellaneous
Algo Trading
Share and discuss algorithms, strateg...
BIOCON - More Information
Biocon Ltd:
Biocon Limited is a biopharmaceutical firm in India, engaged in developing, manufacturing and selling pharmaceutical products for oncology, diabetes and autoimmune diseases in the nation as well as abroad. The company has several sectors of operations such as small molecules, branded formulations, research services and more.
The company is manufacturing insulin lispro, insulin glargine, insulin aspart, recombinant human insulin, monoclonal antibodies, small molecules viz. generic formulations and active pharmaceutical ingredients and more, along with botanical products. Besides that, the company has branded formulation products under brands such as Insugen, BIOMAb, ALZUMAb, EGFR, Basalog and CANMAb. Biocon Limited has certifications such as ISO 9001, ISO 14001:2004, ISO 9001:2000, ISO 15189:2003 and OHSAS 18001:1999. The company has been developing its entire research system based upon small and large molecules, oligonucleotides and antibody-drug conjugates. Clinigene International Ltd and Syngene International Ltd are the two subsidiaries of Biocon Limited. The company has a global intervention in approximately 120 countries.
About Company Information:
Biocon Limited was incepted in 1978 and is headquartered in Bangalore, India. Biocon Limited was found when an Indian entrepreneur signed a joint venture with Ireland based firm Biocon Biochemicals Limited in 1978. The company started manufacturing and exporting enzymes to USA and Europe from 1979. Biocon Biochemicals Limited was acquired by Unilever plc and merged with Unilever’s subsidiary Quest International.
In 1990, the company enhanced its in-house research programme by introducing new technologies. In 1993, the R&D, along with manufacturing facilities of the company, was certified ISO 9001 by RWTUV, Germany. Syngene International Pvt. Ltd was incorporated by the company in 1994 as a Custom Research Company for addressing the exponentially increasing need for outsourced Research & Development in the pharmaceutical sector.
Developing an efficient manufacturing facility, Biocon Limited started to venture its initiatives for human healthcare in the medicine market and business since 1997. In 1998, Unilever had gone for a deal with ICI for selling its speciality chemicals division, which includes Quest International.
A totally automated submerged fermentation plant, for the first time in its history of operation, was commissioned by the company in 2000, for manufacturing speciality pharmaceuticals. Clinigene, India’s first Clinical Research Organisation for providing clinical research and development was commissioned by the company in 2000. US FSA approved Biocon Limited as India’s first pharmaceutical company to manufacture the cholesterol-lowering molecule lovastatin.
In 2005, a commercial agreement was signed by Biocon Limited for supplying insulin API to Asia, Africa and the Middle East. Nation’s largest biotechnology hub, having an integrated set up of manufacturing facilities and research laboratories with a spreading of 90 acres in Karnataka Industrial Areas Development Board—namely, Biocon Park was established by the company in 2006. Country’s largest multi-product Biologics facility was also established at Biocon Park.
An MoU was signed between Biocon and Neopharma, resulting as a joint venture firm Neobiocon in July 2007. A strategic partnership was established between the company and IATRICa, Inc for developing jointly a range of immunoconjugates regarding the immunotherapy of cancers and infectious diseases in January 2008.
BASALOG, long-lasting basal insulin for Type 1 & Type 2 Diabetics were introduced by Biocon Limited in 2009. Biocon Cell was launched as the resultant of the partnership between Biocon Limited and ISB for Innovation Management in the same year. AxiCorp GmbH, the German subsidiary of Biocon had been sold by the company in 2011, to its existing promoters and shareholders. ALZUMAb, was launched by Biocon Limited in 2013 for the psoriasis patients in India.
In 2014, CANMAb – Trastuzumab, a medicine for the treatment of breast cancer was launched by the company in India. A world-class premium devices facility was inaugurated by Biocon at Bangalore in 2015 along with the introduction of Basalog One in India. Mylan and Biocon jointly submitted a proposal for Biosimilar Trastuzumab to USFDA in 2016.
Biocon Limited declared that along with Mylan it is going to enhance the introduction of adalimumab biosimilar in Europe, as Mylan has an in-licensing arrangement with Fujifilm Kyowa Kirin Biologics.
How Biocon Ltd, is categorised as a Pharmaceutical and Healthcare Sector, and Pharmaceutical Industry :
The Pharmaceutical Industry includes companies that derive their business by researching, discovering, developing, manufacturing, and marketing and distributing pharmaceutical medicines and drugs.
Biocon Ltd is categorized under the Health care sector and Hospitals and Medical services Industry. Healthcare sectors consist of firms involved in the medical space. It is one of the multiple sectors that comprise a range of businesses, including ones that offer medical services directly, or to those that work to develop, create and market medical equipment and medicines. It also includes the other services that provide medical insurance and other related products, and many more.
The stocks of health care companies mostly have mixed performance. It is due to the inherent challenges to the industry each year, regulatory uncertainties, fiscal policy concerns, and more.
Biocon Ltd, Competitors and Sector Peers:
Aarey Drugs & Pharmaceuticals Ltd. AARDRU
Aarti Drugs Ltd. AARTDR
Aayush Food & Herbs Ltd. AAYFOO
Abbott India Ltd. ABBIND
ABL Bio-Technologies Ltd. ABLBIO
Addlife Pharma Ltd. ADDPHA
Advik Laboratories Ltd. ADVLAB
Ahlcon Parenterals (India) Ltd. AHLPAR
Ajanta Pharma Ltd. AJAPHL
Aurobindo Pharma Ltd. AUROBP
Bharat Immunological & Biologicals Corporation Ltd. BHAIMM
Biofil Chemicals & Pharmaceuticals Ltd. BIOCHE
Biowin Pharma (India) Ltd. BIOPHA
Bliss GVS Pharma Ltd. BLIGVS
Brabourne Enterprises Ltd.[Amalgamated] RPGLIF
Brawn Biotech Ltd. BRAPHA
Brooks Laboratories Ltd. BROLAB
Cadila Healthcare Ltd. CADHEA
Caplin Point Laboratories Ltd. CAPPOI
Cipla Ltd. CIPLTD
Claris Lifesciences Ltd. CORELA
Colinz Laboratories Ltd. COLILA
Combat Drugs Ltd. COMDRU
Concord Drugs Ltd. CONDRU
Coral Laboratories Ltd. CORLAB
Desh Rakshak Aushdhalaya Ltd. DESRAK
DIL Ltd. DILLIM
Divi's Laboratories Ltd. DIVIL
Dolphin Laboratories Ltd. DOLLAB
Dr. Datsons Labs Ltd. AANLIF
Dr. Reddy's Laboratories Ltd. DR
Dujohn Laboratories Ltd. DUJLAB
Ganga Pharmaceuticals Ltd. GANPHA
Gennex Laboratories Ltd. GENLAB
Genomics Biotech Ltd. GENBIO
GlaxoSmithKline Pharmaceuticals Ltd. GLAPHA
Glenmark Pharmaceuticals Ltd. GLEPHL
IOL Chemicals and Pharmaceuticals Ltd. IOLCHE
Ipca Laboratories Ltd. IPCLAB
Ishita Drugs & Industries Ltd. ISHDRU
J B Chemicals & Pharmaceuticals Ltd. JBCH
Jagsonpal Pharmaceuticals Ltd. JAGPHA
Jenburkt Pharmaceuticals Ltd. JENPHA
JK Pharmachem Ltd. JKPHAL
Jubilant Life Sciences Ltd. JUBILO
Jupiter Bioscience Ltd. JUPIBI
Kabra Drugs Ltd. KABDRU
Kamron Laboratories Ltd. KAMLAB
Lincoln Pharmaceuticals Ltd. LINPHA
Lupin Ltd. LUPLTD
Lyka Labs Ltd. LYKLAB
Madhuveer Com 18 Network Ltd. TOHPHA
Mahavir Advanced Remedies Ltd. INDAME
Makers Laboratories Ltd. MAKLAB
Mangalam Drugs and Organics Ltd. MANDRU
New Heaven Chemicals and Industries Ltd. TRAMED
NGL Fine - Chem Ltd. NGLFIN
Norris Medicines Ltd. NORMED
Novartis India Ltd. NOVAIN
Nutraplus India Ltd. NUTPRO
Omega Labora.Ltd. OMELAB
Oriental Remedies & Herbals Ltd. ORIREM
Ortin Laboratories Ltd. ORTLAB
Piramal Enterprises Ltd. NICPIR
Procter & Gamble Health Ltd. MERCLT
Ranbaxy Laboratories Ltd. RANLAB
RPG Life Sciences Ltd. RPGLI
Rubra Medicaments Ltd. RUBMED
Sanofi India Ltd. AVEPHA
Sun Pharmaceutical Industries Ltd. SUN28
Trans Asia Corporation Ltd. TRAASI
Wockhardt Ltd. WOCLTD
Wyeth Ltd. WYELTD
Yogi Healthcare Ltd. COREHE
Zenith Healthcare Ltd. ZENHEA
Zenlabs Ethica Ltd. SHRLAK
Zenotech Laboratories Ltd. ZENLAB
Zyden Gentec Ltd. ZYDGEN

Market Capitalization	36,660
Enterprise Value	36,305
Price to Earnings	149.8
Price to Book Value	5.15
Return on Capital Employed	0.04
Return on Equity	0.04
Face Value	5
Dividend Yield	NA

BIOCON - 52 Week High	₹682.45
BIOCON - 52 Week Low	₹211.05

Date	Brokerage	Call	Target
30-Oct-19	Geojit Financial Services	Hold	260
24-Oct-19	ICICIdirect.com	Buy	310
24-Oct-19	Nirmal Bang	Accumulate	252
2-Aug-19	AnandRathi	Buy	321
2-Aug-19	Axis Direct	Buy	300

Date	Open	High	Low	Close
Dec 6	288.05	293.35	286.05	289
Dec 5	287.2	289.25	283.9	286.6
Dec 4	284	289	281.15	287.2
Dec 3	299	299	282.85	285.7
Dec 2	283.2	291.95	282.45	285.8

20 Day Moving Average	₹269.42
30 Day Moving Average	₹263.29
50 Day Moving Average	₹252.7
100 Day Moving Average	₹243.42
200 Day Moving Average	₹386.93

CONSOLIDATED	Mar-18	Mar-17	% Change
Revenue	2,425	2,587.9	-0.06
Operating Profit	318	591.8	-0.46
Profit Before Tax	305	536.2	-0.43
Net Income	238	519.3	-0.54

CONSOLIDATED	Mar-19	Mar-18	% Change
Shareholder's Funds	7,115	6,737	0.06
Total Liabilities	1,125	1,045	0.08
Total Assets	8,240	7,783	0.06

CONSOLIDATED	Mar-18	Mar-17	% Change
Cash from Operating Activity	355	185.8	0.91
Cash from Investing Activity	-553	104	-6.32
Cash from Financing Activity	-54	-238.3	-0.77
Net Cash Flow	-252	51.5	-5.89

CONSOLIDATED	Mar-18	Mar-17
Return on Assets	0.03	0.07
Return on Equity	0.04	0.08
Return on Capital Employed	0.04	0.08

3 Year CAGR Growth in Revenue	0.08
3 Year CAGR Growth in Operating Profit	-0.22
3 Year CAGR Growth in EBIDTA	-0.21
3 Year CAGR Growth in Net Income	-0.34
3 Yr CAGR Growth - Diluted EPS	-0.78

5 Year CAGR Growth in Revenue	0.25
5 Year CAGR Growth in Operating Profit	-0.18
5 Year CAGR Growth in EBIDTA	NA
5 Year CAGR Growth in Net Income	-0.14
3 Yr CAGR Growth - Diluted EPS	-0.71